$RGBP Founded in 2012 as a biotechnology company
Post# of 8462
Fully reporting and trades publicly under the symbol: RGBP
Focused on immuno-oncology, stem cell/cancer stem cell, gene silencing
Currently 2 Investigational New Drug applications (IND) filed with the FDA
Three products in preclinical development based on the newly discovered cancer stem cell gene target
Picture
http://www.regenbiopharmainc.com/investor-relations.html